The following is a summary of “Limited added value of systematic spinal cord MRI vs brain MRI alone to classify patients with ...

A new artificial intelligence (AI) tool called MindGlide was found to accurately calculate MS-related brain damage using a ...

A new AI tool, MindGlide, can rapidly analyze routine brain MRI scans to detect subtle changes caused by multiple sclerosis (MS), such as brain shrinkage and lesions.

Previous research has shown that vitamin D deficiency can increase the risk of multiple sclerosis (MS ... 60.3% experienced a ...

Frexalimab was well tolerated and maintained disease control over two years in adults with relapsing MS in an open-label ...

Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed.

Researchers at UCL have developed an innovative AI tool called MindGlide, designed to transform the way MS treatments are ...

Researchers hope MindGlide will unlock valuable information from millions of untapped brain images that were previously difficult or impossible to understand.

Tolebrutinib, a brain-penetrant BTK inhibitor, may fill a significant unmet need by delaying disability progression in patients with non-relapsing secondary progressive multiple sclerosis.

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of ...

UK researchers have developed a new artificial intelligence (AI) tool that can help interpret and assess how well treatment ...